Demegestone
Systematic (IUPAC) name | |
---|---|
17-methyl-19-norpregna-4,9-diene-3,20-dione | |
Identifiers | |
CAS Number | 10116-22-0 |
ATC code | G03DB05 (WHO) |
PubChem | CID 93057 |
ChemSpider | 84009 |
Synonyms | RU-2453 |
Chemical data | |
Formula | C21H28O2 |
Molar mass | 312.446 g/mol |
| |
|
Demegestone (INN) (brand name Lutionex), also known as 17-methyl-19-norpregna-4,9-diene-3,20-dione, is a 19-norprogesterone derivative and steroidal progestin which was introduced by Roussel in France in 1974.[1][2] Like other 19-norprogesterone derivatives, it has relatively high affinity for the progesterone receptor and shows little or no activity at other steroid hormone receptors.[3]
See also
References
- ↑ C.R. Ganellin; David J. Triggle (21 November 1996). Dictionary of Pharmacological Agents. CRC Press. pp. 582–. ISBN 978-0-412-46630-4.
- ↑ William Andrew Publishing (22 October 2013). Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. Elsevier. pp. 1215–. ISBN 978-0-8155-1856-3.
- ↑ Ian Milsom (2006). Contraception and Family Planning. Elsevier Health Sciences. pp. 102–. ISBN 0-444-51828-2.
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.